Traditionally majority of eukaryotic gene expression is influenced by transcriptional and post-
transcriptional events. Alterations in the expression of proteins that act post-transcriptionally …

Highlights•RNA-binding proteins (RBPs) are essential for tumorigenesis, immune evasion,
invasion, migration and metastasis, hence promising drug targets in cancer therapy.•Small …

Human antigen R (HuR) is a ubiquitously expressed RNA-binding protein, which functions
as an RNA regulator. Overexpression of HuR correlates with high grade tumours and poor …

The RNA-binding protein Hu antigen R (HuR) is a post-transcriptional regulator critical in
several types of diseases, including cancer, making it a promising therapeutic target. We …

Lipopolysaccharide (LPS) exposure to macrophages induces an inflammatory response,
which is regulated at the transcriptional and post-transcriptional levels. HuR (ELAVL1) is an …

The posttranslational modification of proteins critically influences many biological processes
and is a key mechanism that regulates the function of the RNA-binding protein Hu antigen R …

Human antigen R (HuR), also known as ELAVL1, is a widely expressed RNA‐binding
protein (RBP) that has a significant impact on the development and advancement of tumors …

This study was performed to determine the effect of human umbilical cord mesenchymal
stem cells (hucMSCs) treatment on pulmonary fibrosis and investigate the circFOXP1 …

Objectives There is emerging evidence that long non-coding RNA component of
mitochondrial RNA processing endoribonuclease (lncRNA RMRP) is involved in acute …

Celecoxib (CLX), a selective inhibitor for cyclooxygenase 2 (COX-2), has manifested
potential activity against diverse types of cancer. However, low bioavailability and …